Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M.D., Ph.D. Following the departure of GSK CEO Emma ...
Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the CompanyDonn Casale, ...
The successor company to Purdue Pharma, the recently dissolved firm that made the controversial prescription opioid OxyContin, announced this week the appointment of a longtime pharmaceutical ...
STAMFORD, Conn., July 1, 2026 /PRNewswire/ -- Knoa Pharma today announced the appointment of Michael Goettler as President and Chief Executive Officer, effective July 6. Knoa Pharma, which began ...
Mr. Lind succeeds Company founder Lawrence G. Miller, MD, who is transitioning to Vice Chair of the Board Mr. Lind brings significant prior CEO, commercial, financial and capital markets experience, ...
To become a CEO, you have to be willing to learn. And that’s true even if you’re starting your own venture from the ground up. My road to becoming CEO of a large international pharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results